- Barnhart ER. Physicians’desk reference
(45th edic.) Orandell NJ. Medical Economics Inc, 1991.
- Bove G, Nielsson N. Spinal manipulation in the treatment of
episodic tension-type headache. A randomised controlled trial. JAMA 1998; 280: 1576-1579.
- Blue Book of Practical Neurology. Vol. 17. Headache. Editors, PJ
Goadsby, SD Silverstein. Butterworth-Heinemann, Boston, 1997.
- Brennum J, Kjeldsen M, olsen J. The 5-HT1-like agonist sumatriptan
has a significant effect in chonic tension-type headache. Cephalalgia 1992; 12: 375-379.
- Brennum L, Brinck T, Schiver L, et al. Sumatriptan has no
clinically relevant effect in the treatment of episodic tension-type headache. Eur J
Neurol 1996; 3: 23-28.
- Curter FM, Moskowitz MA. Headache syndromes. In Ed. Rosenberg RN,
Pleasure DF. Comprehensive Neurology, John Wiley & Sons Inc. N.Y., 1998, pp. 355-369.
- Danish Neurological Society and Danish Headache Society.
Guidelines for the management of headache. Cephalalgia 1998; 18: 9-22.
- Ferrari MD. Migraine. Lancet 1998; 351: 1043-1051.
- Friedman JM, Polifka JE. Teratogenic effects of drugs: a resource
for clinicians (TERIS). Baltimore. John Hopkins University Press, 1994.
- Headache Classification Committee of the International Headache
Society. Classification and diagnostic criteria for headache disorders, cranial
neuralgias, and facial pain. Cephalalgia 1988; 8(Supp 7): 1-96.
- Lassen LH, Ashina M, Christiansen I. Nitric oxide synthase
inhibition: a new principle in the treatment of migraine attacks. Cephalalgia 1998; 18:
27-32
- Lipton RB, Amatniek JC, Ferrari MD, Gross M. Migraine. Identifying
and removing barriers to care. Neurology 1994; 44 (suppl 4): S63-S68.
- Lissovoy G, Lazarus SS. The economic cost of migraine. Present
state of knowledge. Neurology 1994; 44 (suppl 4): S56-S62.
- Mauskop A, Altura BT, Cracco RQ, et al. Intravenous magnesium
sulfate relieves migraine attacks in patients with low serum ionised magnesium levels; a
pilot study. Clinical Science 1995; 89: 633-636.
- May A, Bahra A, Buchel C, et al. Hypothalamic activation in
cluster headache attacks. The Lancet 1998; 351: 275-278.
- Moskowitz M. Aura and Cortical Spreading Depression, presentation
at American Neurological Association, Seattle, Wa, October, 1999.
- Peroutka SJ. Genetic evaluation of migraine. In Blue Book of
Practical Neurology. Vol. 17. Headache. Editors, PJ Goadsby, SD Silverstein.
Butterworth-Heinemann, Boston, 1997; 107-114.
- Ramadan NM, Schultz LL, Gilkey SJ. Migraine prophylactic drugs:
proof of efficacy, utilization and cost. Cephalalgia 1997; 17: 73-80.
- Schoenen J, Jacquy J, and Lanaerts M. Effectiveness of high-dose
rivoflavin in migraine prophylaxis. Neurology 1998; 50: 466-470.
- Silberstein SD, Lipton RB, Goadsby PJ. Headache in Clinical
Practice. StLouis: Mosby-Year Boock; 1998: 101-114.
- Solomon GD, Lee TG, Solomon CS. Manual Clínico sobre la migraña.
Segunda edición. London: Science Press Ltd;1998.
- Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence.
Neurology 1994; 44 (suppl 4): S17-S23.
- Sutton CL, Weisber LA. Which headache patients should undergo
neuroimaging?. Emergency Medicine 1999; 31: 12-34.
- Tfelt-Hansen P, Saxena PR, Dahlöf C, et al. Ergotamine in the
acute treatment of migraine. A review and European consensus. Brain 2000; 123: 9-18.
- Yamamura H, Malick A, Chamberlin NL, Burstein R. Cardiovascular
and neuronal responses to head stimulation reflect central sensitization and cutaneous
allodynia in rat model of migraine. J Neurophysiol 1999; 81: 479-493.
- Actitud diagnóstica y terapéutica en la
cefalea. Recomendaciones 1999. Grupo de estudio de cefalea de la Sociedad Española de
Neurología. Ed. Ergón, S.A., Madrid 1999.
- Adelman JU, Brod A, Von Seggern RL, et al. Migraine preventive
medications: a reappraisal. Cephalalgia 1998; 18: 605-611.
- Capobianco DJ, Cheshire WP, Cambell JK. An overview of the
diagnosis and pharmacologic treatment on migraine. Mayo Clin Proc 1996; 71: 1055-1066.
- Dinier HC, Kaube HE, Limmroth V. A practical guide to the
management and prevention of migraine. Drugs 1998; 56: 811-824.
- Holroyd KA, Penzien DB, Cordingley GE. Propranolol in the
management of recurrent migraine: a metanalytic review. Headache 1991; 31: 333-340.
- Pryse-Phillips WEM, Dodick DW, Edmeads JG, et al. Guidelines for
the diagnosis and treatment of migraine in clinical practice. Can Med Assoc J 1997; 156:
1273-1287.
- Ramadan NM, Schultz LL, Gilkey SJ. Migraine prophylactic drugs:
proof of efficacy, utilization and cost. Cephalalgia 1997; 17: 73-80.
- Rapoport AM, Adelman JU. Cost of migraine management: A
pharmacoeconomic overview. Am J Man Care 1998; 84: 531-545.
- Silberstein SD. Preventive treatment og migraine: an overview.
Cephalalgia 1997; 17: 67-72.
- Solomon GD, Lee TG, Solomon CS. Manual Clínico sobre la migraña.
Segunda edición. Londres: Science Press Ltd;1998.
- Welch KMA. Drug therapy of migraine. New Engl J Med 1993; 33:
1476-1483.
